Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 4/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.57 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.56 |
| ▸ | BAX | Q07812 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL238577 | 1.00 | LTA4H (0.57) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL236811 | 0.94 | ACACB (0.54) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL1624304 | 0.93 | KMT2A (0.52) | PARP10SRD5A2HPGDELANE | |
| SCHEMBL27352197 | 0.90 | TDP1 (0.54) | LTA4HTSHRHPGDSMN1; SMN2ELANE | |
| SCHEMBL9241160 | 0.90 | TDP1 (0.54) | LTA4HTSHRHPGDSMN1; SMN2ELANE | |
| SCHEMBL9353455 | 0.90 | TDP1 (0.54) | LTA4HTSHRHPGDSMN1; SMN2ELANE | |
| SCHEMBL18073 | 0.90 | TDP1 (0.54) | LTA4HTSHRHPGDSMN1; SMN2ELANE | |
| SCHEMBL9353461 | 0.90 | TDP1 (0.54) | LTA4HTSHRHPGDSMN1; SMN2ELANE | |
| Bicarbonate SCHEMBL1393750 | 0.87 | TDP1 (0.52) | LTA4HTSHRHPGDSMN1; SMN2ELANE | |
| SCHEMBL10945396 | 0.87 | TDP1 (0.52) | LTA4HTSHRHPGDSMN1; SMN2ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 391 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600116-B2 | Special polymer layers for faster laminability of multilayer structures | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-14 | — | — | US | disclosed |
| EP-3055342-B1 | PROCESS FOR PREPARING POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES USING A SALT OF A WEAK ACID | COVESTRO DEUTSCHLAND AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12365775-B2 | Process for partial colouring of plastic parts using solid colourants in colour- carrier layers | COVESTRO DEUTSCHLAND AG (DE) | 2025-07-22 | — | — | US | disclosed |
| US-20250205963-A1 | METHOD FOR PRODUCING A PLASTIC MOLDING | tooz technologies GmbH (DE) | 2025-06-26 | — | — | US | disclosed |
| US-20250091332-A1 | FILM STRUCTURE SUITABLE FOR RAPID LAMINATION | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-20 | — | — | US | disclosed |
| EP-3055344-B1 | POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-12 | — | — | EP | disclosed |
| US-20240308191-A1 | SPECIAL POLYMER LAYERS FOR FASTER LAMINABILITY OF MULTILAYER STRUCTURES | COVESTRO DEUTSCHLAND AG (DE) | 2024-09-19 | — | — | US | disclosed |
| US-12023953-B2 | Layer structure with modified structure, and production thereof | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2024-07-02 | — | — | US | disclosed |
| US-20240209169-A1 | PROCESS FOR PARTIAL COLOURING OF PLASTIC PARTS USING SOLID COLOURANTS IN COLOUR-CARRIER LAYERS | COVESTRO DEUTSCHLAND AG (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4370334-A1 | FILM STRUCTURE SUITABLE FOR RAPID LAMINATION | Covestro Deutschland AG (DE) | 2024-05-22 | — | — | EP | disclosed |
| US-20020188091-A1 | Process for continuous production of polycarbonates and a reactor therefor | COVESTRO DEUTSCHLAND AG (DE) | 2002-12-12 | — | — | US | disclosed |
| WO-2002085967-A1 | METHOD FOR CONTINUOUSLY PRODUCING POLYCARBONATES ACCORDING TO THE MELT TRANSESTERIFICATION METHOD | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-31 | — | — | WO | disclosed |
| EP-1253163-A1 | Process for continuously preparing polycarbonates by transesterification | BAYER AG (DE) | 2002-10-30 | — | — | EP | disclosed |
| WO-2002077067-A2 | METHOD FOR PRODUCING POLYCARBONATES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-03 | — | — | WO | disclosed |
| WO-2002077066-A1 | METHOD FOR PRODUCING OLIGOCARBONATES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-03 | — | — | WO | disclosed |
| US-20020137874-A1 | Process for producing oligocarbonates | COVESTRO DEUTSCHLAND AG (DE) | 2002-09-26 | — | — | US | disclosed |
| JP-2002037875-A | METHOD OF PRODUCING AROMATIC POLYCARBONATE | ASAHI KASEI CORP | 2002-02-06 | — | — | JP | disclosed |
| JP-2002037874-A | METHOD OF PRODUCING AROMATIC POLYCARBONATE | ASAHI KASEI CORP | 2002-02-06 | — | — | JP | disclosed |
| JP-2002037878-A | METHOD OF PRODUCING AROMATIC POLYCARBONATE | ASAHI KASEI CORP | 2002-02-06 | — | — | JP | disclosed |
| JP-2002037871-A | METHOD OF PRODUCING AROMATIC POLYCARBONATE | ASAHI KASEI CORP | 2002-02-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600116-B2 | Special polymer layers for faster laminability of multilayer structures | ASH2L, SMC2, ELL | LTA4H 3220/4885TSHR 4367/4885PARP10 1593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.